By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


AMAG Pharmaceuticals, Inc. 

1100 Winter Street

Waltham  Massachusetts  02451  U.S.A.
Phone: 617-498–3300 Fax: 617-499-3361


Founded in 1981, AMAG Pharmaceuticals is committed to improving the health outcomes of patients through the development and commercialization of specialty pharmaceutical products.

AMAG currently markets a therapeutic intravenous iron compound for the treatment of iron deficiency anemia in adult patients with chronic kidney disease (CKD) and an oral rinse for the management of oral mucositis in the United States. To learn more about our products, click here. Along with driving organic growth of its lead product, AMAG intends to expand its portfolio with additional commercial-stage specialty pharmaceuticals. The company is seeking complementary products that leverage the company's commercial footprint and focus on hematology and oncology centers and hospital infusion centers.
Our iron oxide particles are composed of bioavailable iron that is easily absorbed by the body and incorporated into the body's iron stores. As a result, products using our core technology are well suited for use in intravenous iron replacement therapy.

Key Statistics

Ownership: Public

Web Site: AMAG Pharmaceuticals, Inc.
Employees: 51-200
Symbol: AMAG


Company News
AMAG Pharmaceuticals, Inc. (AMAG) Provides Business Update And 2015 Financial Guidance 1/12/2015 7:17:20 AM
AMAG Pharmaceuticals, Inc. (AMAG) To Present At The 33rd Annual J.P. Morgan Healthcare Conference 1/9/2015 8:09:42 AM
AMAG Pharmaceuticals, Inc. (AMAG) Announces Presentation At Jefferies and Co. 2014 Global Healthcare Conference In London 11/14/2014 10:21:46 AM
AMAG Pharmaceuticals, Inc. (AMAG) Completes Acquisition Of Lumara Health's Maternal Health Business 11/13/2014 7:32:05 AM
AMAG Pharmaceuticals, Inc. (AMAG) Reports Financial Results For Third Quarter And Nine Months Ended September 30, 2014 10/30/2014 8:36:09 AM
AMAG Pharmaceuticals, Inc. (AMAG) To Host Conference Call On October 30, 2014 At 8:00 A.M. ET To Discuss Financial Results For The Quarter And Nine Months Ended September 30, 2014 10/27/2014 9:58:47 AM
AMAG Pharmaceuticals, Inc. (AMAG) Shells Out $675 Million For Women's Health Company Lumara Health 9/29/2014 6:14:41 AM
AMAG Pharmaceuticals, Inc. (AMAG) Appoints Judith Johnson, M.D. As Vice President Of Pharmacovigilance And Pharmacoepidemiology 9/16/2014 11:25:31 AM
AMAG Pharmaceuticals, Inc. (AMAG) Announces Appointment Of John A. Fallon, M.D. To Board Of Directors 9/8/2014 8:40:40 AM
AMAG Pharmaceuticals, Inc. (AMAG) To Present At Upcoming Investor Conferences 8/29/2014 8:50:41 AM